Purchases and Sales Made in Q4 2023 in Keros Therapeutics, Inc. (KROS)
This table provides information about the institutional ownership of Keros Therapeutics, Inc. (KROS) during Q4 2023. The information is specifically focused on institutions that hold shares of Keros Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-135K- 18.74% |
$3.65M - $5.53M
|
584K
$6.3M
|
|
|
Feb 13, 2024
Q4 2023
|
Alkeon Capital Management LLC
New York, NY |
SELL
|
- |
-178K- 10.59% |
$4.82M - $7.29M
|
1.5M
$16.2M
|
|
|
Feb 14, 2024
Q4 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-226K- 17.8% |
$6.12M - $9.26M
|
1.04M
$11.2M
|
|
|
Feb 14, 2024
Q4 2023
|
Braidwell LP
Stamford, CT |
SELL
|
- |
-238K- 17.56% |
$6.46M - $9.78M
|
1.12M
$12.1M
|
|
|
Feb 14, 2024
Q4 2023
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-246K- 16.24% |
$6.67M - $10.1M
|
1.27M
$13.7M
|